Medtech Missteps: What's at Stake Beyond the Bottom Line The latest earnings reports from Medtronic and Intuitive Surgical have left investors puzzled, but beneath the surface lies a complex web of challenges that threaten to upend the entire sector.
Tariffs, competition, and innovation are all taking their toll on these medical device giants. Medtronic's recent financial results were mixed: revenue increased by 9.
9% in its fourth quarter, but adjusted earnings per share (EPS) declined by 4. 3%. The company's guidance for the next fiscal year fell short of analysts' expectations, sending the stock lower.